539561 logo

Supha Pharmachem Limited Stock Price

BSE:539561 Community·₹181.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

539561 Share Price Performance

₹0
-2.28 (-100.00%)
₹0
-2.28 (-100.00%)
Price ₹0

539561 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with mediocre balance sheet.

4 Risks
1 Reward

Supha Pharmachem Limited Key Details

₹5.3b

Revenue

₹5.1b

Cost of Revenue

₹154.9m

Gross Profit

₹32.3m

Other Expenses

₹122.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Mar 30, 2026
0.30
2.94%
2.33%
1,033.8%
View Full Analysis

About 539561

Founded
1988
Employees
7
CEO
Adarsh Munjal
WebsiteView website
www.remlife.com

Supha Pharmachem Limited, a pharmaceutical company, trades and sells active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, iodine, selenium metal powder, and trimethyl sulfoxonium iodide. It also provides tartaric acid salt, thiophenetosylate, couple amine hydrochloride, pantoprazole sulphide, chloro compound, benzimidazole, pantoprazole n-oxide, 4-chloro benzhydryl piperazine, cetirizine base, levo CBP, 2 PMS, indole II, indole III, and R- amide. The company was formerly known as Remedium Lifecare Limited and changed its name to Supha Pharmachem Limited in December 2025. Supha Pharmachem Limited was incorporated in 1988 and is based in Mumbai, India.

Recent 539561 News & Updates

Recent updates

No updates